Dr. Mike Roizen
Dr. Mike Roizen is chief medical officer at the Cleveland Clinic Wellness Institute, an award-winning author, and has been the doctor to eight Nobel Prize winners and more than 100 Fortune 500 CEOs.

Dr. Mike Roizen

Tags: weight loss | glp-1 | insulin | dr. roizen
OPINION

Maintaining Weight Loss From GLP-1s

Michael Roizen, M.D. By Wednesday, 08 April 2026 11:42 AM EDT Current | Bio | Archive

A review in BMJ found that when people have been on any weight-loss drug for around 10 months and then stop taking it, they return to their baseline weight in 1.7 years.

And if they were taking semaglutide or tirzepatide, they rebounded in 1.5 years.

That's pretty discouraging, especially because many people want to discontinue these medications when they reach their target weight. And less than 25% of users stay on a GLP-1 for a full year, whether they meet their goals or not.

Fortunately, a new study offers a way to reduce your prescribed routine and even increase your weight loss.

Research published in the journal Obesity says that taking GLP-1 medications at the same dose every two weeks allowed participants to retain their weight loss and even lose a bit more.

The reduced-dose schedule of around 36 weeks saw patients’ weight go from an average of 194 pounds before starting treatment to 163 pounds when they transitioned to the less-frequent dosing. And while taking the meds every two weeks, they lost four more pounds.

This may work because it gives your body a chance to adjust to a lower level of appetite suppression, and stabilize insulin and glucose levels. Then when you go off the medication, you can more easily use lifestyle changes to maintain your healthier weight. (Although I say stay on GLP-1s if you can — they have many additional benefits.)

© King Features Syndicate


DrRoizen
Research published in the journal Obesity says that taking GLP-1 medications at the same dose every two weeks allowed participants to retain their weight loss and even lose a bit more.
weight loss, glp-1, insulin, dr. roizen
234
2026-42-08
Wednesday, 08 April 2026 11:42 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Free Newsmax E-Alerts
Email:
Country:
Zip Code:
Privacy: We never share your email.
 
Find Your Condition
Take A Look At This
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved